The Food and Drug Administration issued guidance in February for clinical trials for early-stage Alzheimer's medications.
February 11, 2013
The Food and Drug Administration issued draft guidance Thursday on clinical trials for early-stage Alzheimer's drugs.
Scientists have developed an antibody-screening blood test that may one day be used to detect diseases such as Alzheimer's.
An international group of dementia experts is proposing a change in the definition of Alzheimer's disease. They want to be able to diagnose the condition earlier and provide interventional treatments, according to recent reports.
